Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction
Background The objective of this study was to evaluate the simultaneous evolution of 5 cardiovascular magnetic resonance–derived myocardial viability indexes. Methods We studied 72 patients with a first ST-elevation myocardial infarction and sustained TIMI 3 flow. In the first week and in the sixth...
Gespeichert in:
| Veröffentlicht in: | The American heart journal 2007-04, Vol.153 (4), p.649-655 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 655 |
|---|---|
| container_issue | 4 |
| container_start_page | 649 |
| container_title | The American heart journal |
| container_volume | 153 |
| creator | Bodí, Vicente, MD, FESC Sanchis, Juan, MD, FESC Lopez-Lereu, Maria P., MD Nunez, Julio, MD Mainar, Luis, MD Pellicer, Mauricio, MD Sanz, Roberto, PhD Gomez, Cristina, PhD Bosch, Maria J., MD Husser, Oliver Chorro, Francisco J., MD, FESC Llacer, Angel, MD, FESC |
| description | Background The objective of this study was to evaluate the simultaneous evolution of 5 cardiovascular magnetic resonance–derived myocardial viability indexes. Methods We studied 72 patients with a first ST-elevation myocardial infarction and sustained TIMI 3 flow. In the first week and in the sixth month of the study, using cardiovascular magnetic resonance imaging, we determined wall thickening (WT) and the following viability indexes: wall thickness, WT with low-dose dobutamine, microvascular perfusion in first-pass imaging, microvascular obstruction in late-enhancement imaging, and transmural extent of necrosis. Results In 250 dysfunctional segments, the evolution outcomes for the viability indexes were as follows: (1) wall thickness thinned (8.6 ± 2.9 versus 7.7 ± 3 mm, P < .001), (2) WT with low-dose dobutamine improved (1.5 ± 1.9 versus 2.6 ± 3 mm, P < .001), (3) the number of segments showing abnormal microvascular perfusion in first-pass imaging decreased (22% versus 7%, P < .001), (4) the number of segments showing microvascular obstruction in late-enhancement imaging decreased (14% versus 2%, P < .001), and (5) the transmural extent of necrosis remained stable throughout follow-up (56% ± 40% versus 54% ± 39%, P = .3). Conclusions After reperfused myocardial infarction, dynamic changes in wall thickness, contractile reserve, microvascular perfusion, and microvascular obstruction take place. These changes may affect their accuracy as viability indexes early after myocardial infarction. The transmural extent of necrosis does not vary, however. |
| doi_str_mv | 10.1016/j.ahj.2006.12.023 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70313584</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0002870307000580</els_id><sourcerecordid>3238237781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c464t-a52841e42361a7f7dc70b44aeb49c851ee991e870b845b97eb8c41d45f5add283</originalsourceid><addsrcrecordid>eNp9ks-K1TAUxoMoznX0AdxIQXTXmjRJkyAMyDD-gQEX6jqkyammts01aYt35zv4hj6JqffChVm4SgK_7-Sc7zsIPSW4Ipg0r_rKfOurGuOmInWFa3oP7QhWomwEY_fRDmNcl1JgeoEepdTnZ1PL5iG6IIJKSrHYoXSzhmGZfZiK0BW8sCY6H1aT7DKYWIzm6wSzt0WEFCYzWfjz67eD6FdwxepN6wc_Hwo_OfgJqTDdDDGze4jdkjIyHsK_imbITGei3X56jB50Zkjw5HReoi9vbz5fvy9vP777cP3mtrSsYXNpeC0ZAVbThhjRCWcFbhkz0DJlJScAShHI47WS8VYJaKVlxDHeceNcLeklenmsu4_hxwJp1qNPFobBTBCWpLMxhHLJMvj8DtiHJU65N004Zg1WlG8UOVI2hpQidHof_WjiQROstzx0r3MeestDk1rnPLLm2any0o7gzopTABl4cQKy5WboYvbYpzOnFBZKqMy9PnKQDVs9RJ2sh5yH8xHsrF3w_23j6o7aDn7y-cPvcIB0nlanLNCftsXZ9gaLfOMS078B4b9K</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1504609354</pqid></control><display><type>article</type><title>Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Bodí, Vicente, MD, FESC ; Sanchis, Juan, MD, FESC ; Lopez-Lereu, Maria P., MD ; Nunez, Julio, MD ; Mainar, Luis, MD ; Pellicer, Mauricio, MD ; Sanz, Roberto, PhD ; Gomez, Cristina, PhD ; Bosch, Maria J., MD ; Husser, Oliver ; Chorro, Francisco J., MD, FESC ; Llacer, Angel, MD, FESC</creator><creatorcontrib>Bodí, Vicente, MD, FESC ; Sanchis, Juan, MD, FESC ; Lopez-Lereu, Maria P., MD ; Nunez, Julio, MD ; Mainar, Luis, MD ; Pellicer, Mauricio, MD ; Sanz, Roberto, PhD ; Gomez, Cristina, PhD ; Bosch, Maria J., MD ; Husser, Oliver ; Chorro, Francisco J., MD, FESC ; Llacer, Angel, MD, FESC</creatorcontrib><description>Background The objective of this study was to evaluate the simultaneous evolution of 5 cardiovascular magnetic resonance–derived myocardial viability indexes. Methods We studied 72 patients with a first ST-elevation myocardial infarction and sustained TIMI 3 flow. In the first week and in the sixth month of the study, using cardiovascular magnetic resonance imaging, we determined wall thickening (WT) and the following viability indexes: wall thickness, WT with low-dose dobutamine, microvascular perfusion in first-pass imaging, microvascular obstruction in late-enhancement imaging, and transmural extent of necrosis. Results In 250 dysfunctional segments, the evolution outcomes for the viability indexes were as follows: (1) wall thickness thinned (8.6 ± 2.9 versus 7.7 ± 3 mm, P < .001), (2) WT with low-dose dobutamine improved (1.5 ± 1.9 versus 2.6 ± 3 mm, P < .001), (3) the number of segments showing abnormal microvascular perfusion in first-pass imaging decreased (22% versus 7%, P < .001), (4) the number of segments showing microvascular obstruction in late-enhancement imaging decreased (14% versus 2%, P < .001), and (5) the transmural extent of necrosis remained stable throughout follow-up (56% ± 40% versus 54% ± 39%, P = .3). Conclusions After reperfused myocardial infarction, dynamic changes in wall thickness, contractile reserve, microvascular perfusion, and microvascular obstruction take place. These changes may affect their accuracy as viability indexes early after myocardial infarction. The transmural extent of necrosis does not vary, however.</description><identifier>ISSN: 0002-8703</identifier><identifier>EISSN: 1097-6744</identifier><identifier>DOI: 10.1016/j.ahj.2006.12.023</identifier><identifier>PMID: 17383307</identifier><identifier>CODEN: AHJOA2</identifier><language>eng</language><publisher>New York, NY: Mosby, Inc</publisher><subject>Angioplasty ; Biological and medical sciences ; Cardiology ; Cardiology. Vascular system ; Cardiovascular ; Confidence intervals ; Coronary heart disease ; Enzymes ; Female ; Heart ; Heart attacks ; Humans ; Intubation ; Magnetic Resonance Imaging ; Male ; Medical sciences ; Middle Aged ; Myocardial Infarction - diagnosis ; Myocardial Infarction - therapy ; Myocardial Reperfusion ; Studies ; Veins & arteries</subject><ispartof>The American heart journal, 2007-04, Vol.153 (4), p.649-655</ispartof><rights>Mosby, Inc.</rights><rights>2007 Mosby, Inc.</rights><rights>2008 INIST-CNRS</rights><rights>Copyright Elsevier Limited Apr 2007</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c464t-a52841e42361a7f7dc70b44aeb49c851ee991e870b845b97eb8c41d45f5add283</citedby><cites>FETCH-LOGICAL-c464t-a52841e42361a7f7dc70b44aeb49c851ee991e870b845b97eb8c41d45f5add283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1504609354?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976,64364,64366,64368,72218</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=19907979$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17383307$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bodí, Vicente, MD, FESC</creatorcontrib><creatorcontrib>Sanchis, Juan, MD, FESC</creatorcontrib><creatorcontrib>Lopez-Lereu, Maria P., MD</creatorcontrib><creatorcontrib>Nunez, Julio, MD</creatorcontrib><creatorcontrib>Mainar, Luis, MD</creatorcontrib><creatorcontrib>Pellicer, Mauricio, MD</creatorcontrib><creatorcontrib>Sanz, Roberto, PhD</creatorcontrib><creatorcontrib>Gomez, Cristina, PhD</creatorcontrib><creatorcontrib>Bosch, Maria J., MD</creatorcontrib><creatorcontrib>Husser, Oliver</creatorcontrib><creatorcontrib>Chorro, Francisco J., MD, FESC</creatorcontrib><creatorcontrib>Llacer, Angel, MD, FESC</creatorcontrib><title>Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction</title><title>The American heart journal</title><addtitle>Am Heart J</addtitle><description>Background The objective of this study was to evaluate the simultaneous evolution of 5 cardiovascular magnetic resonance–derived myocardial viability indexes. Methods We studied 72 patients with a first ST-elevation myocardial infarction and sustained TIMI 3 flow. In the first week and in the sixth month of the study, using cardiovascular magnetic resonance imaging, we determined wall thickening (WT) and the following viability indexes: wall thickness, WT with low-dose dobutamine, microvascular perfusion in first-pass imaging, microvascular obstruction in late-enhancement imaging, and transmural extent of necrosis. Results In 250 dysfunctional segments, the evolution outcomes for the viability indexes were as follows: (1) wall thickness thinned (8.6 ± 2.9 versus 7.7 ± 3 mm, P < .001), (2) WT with low-dose dobutamine improved (1.5 ± 1.9 versus 2.6 ± 3 mm, P < .001), (3) the number of segments showing abnormal microvascular perfusion in first-pass imaging decreased (22% versus 7%, P < .001), (4) the number of segments showing microvascular obstruction in late-enhancement imaging decreased (14% versus 2%, P < .001), and (5) the transmural extent of necrosis remained stable throughout follow-up (56% ± 40% versus 54% ± 39%, P = .3). Conclusions After reperfused myocardial infarction, dynamic changes in wall thickness, contractile reserve, microvascular perfusion, and microvascular obstruction take place. These changes may affect their accuracy as viability indexes early after myocardial infarction. The transmural extent of necrosis does not vary, however.</description><subject>Angioplasty</subject><subject>Biological and medical sciences</subject><subject>Cardiology</subject><subject>Cardiology. Vascular system</subject><subject>Cardiovascular</subject><subject>Confidence intervals</subject><subject>Coronary heart disease</subject><subject>Enzymes</subject><subject>Female</subject><subject>Heart</subject><subject>Heart attacks</subject><subject>Humans</subject><subject>Intubation</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Myocardial Infarction - diagnosis</subject><subject>Myocardial Infarction - therapy</subject><subject>Myocardial Reperfusion</subject><subject>Studies</subject><subject>Veins & arteries</subject><issn>0002-8703</issn><issn>1097-6744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9ks-K1TAUxoMoznX0AdxIQXTXmjRJkyAMyDD-gQEX6jqkyammts01aYt35zv4hj6JqffChVm4SgK_7-Sc7zsIPSW4Ipg0r_rKfOurGuOmInWFa3oP7QhWomwEY_fRDmNcl1JgeoEepdTnZ1PL5iG6IIJKSrHYoXSzhmGZfZiK0BW8sCY6H1aT7DKYWIzm6wSzt0WEFCYzWfjz67eD6FdwxepN6wc_Hwo_OfgJqTDdDDGze4jdkjIyHsK_imbITGei3X56jB50Zkjw5HReoi9vbz5fvy9vP777cP3mtrSsYXNpeC0ZAVbThhjRCWcFbhkz0DJlJScAShHI47WS8VYJaKVlxDHeceNcLeklenmsu4_hxwJp1qNPFobBTBCWpLMxhHLJMvj8DtiHJU65N004Zg1WlG8UOVI2hpQidHof_WjiQROstzx0r3MeestDk1rnPLLm2any0o7gzopTABl4cQKy5WboYvbYpzOnFBZKqMy9PnKQDVs9RJ2sh5yH8xHsrF3w_23j6o7aDn7y-cPvcIB0nlanLNCftsXZ9gaLfOMS078B4b9K</recordid><startdate>20070401</startdate><enddate>20070401</enddate><creator>Bodí, Vicente, MD, FESC</creator><creator>Sanchis, Juan, MD, FESC</creator><creator>Lopez-Lereu, Maria P., MD</creator><creator>Nunez, Julio, MD</creator><creator>Mainar, Luis, MD</creator><creator>Pellicer, Mauricio, MD</creator><creator>Sanz, Roberto, PhD</creator><creator>Gomez, Cristina, PhD</creator><creator>Bosch, Maria J., MD</creator><creator>Husser, Oliver</creator><creator>Chorro, Francisco J., MD, FESC</creator><creator>Llacer, Angel, MD, FESC</creator><general>Mosby, Inc</general><general>Elsevier</general><general>Elsevier Limited</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88C</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20070401</creationdate><title>Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction</title><author>Bodí, Vicente, MD, FESC ; Sanchis, Juan, MD, FESC ; Lopez-Lereu, Maria P., MD ; Nunez, Julio, MD ; Mainar, Luis, MD ; Pellicer, Mauricio, MD ; Sanz, Roberto, PhD ; Gomez, Cristina, PhD ; Bosch, Maria J., MD ; Husser, Oliver ; Chorro, Francisco J., MD, FESC ; Llacer, Angel, MD, FESC</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c464t-a52841e42361a7f7dc70b44aeb49c851ee991e870b845b97eb8c41d45f5add283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Angioplasty</topic><topic>Biological and medical sciences</topic><topic>Cardiology</topic><topic>Cardiology. Vascular system</topic><topic>Cardiovascular</topic><topic>Confidence intervals</topic><topic>Coronary heart disease</topic><topic>Enzymes</topic><topic>Female</topic><topic>Heart</topic><topic>Heart attacks</topic><topic>Humans</topic><topic>Intubation</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Myocardial Infarction - diagnosis</topic><topic>Myocardial Infarction - therapy</topic><topic>Myocardial Reperfusion</topic><topic>Studies</topic><topic>Veins & arteries</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bodí, Vicente, MD, FESC</creatorcontrib><creatorcontrib>Sanchis, Juan, MD, FESC</creatorcontrib><creatorcontrib>Lopez-Lereu, Maria P., MD</creatorcontrib><creatorcontrib>Nunez, Julio, MD</creatorcontrib><creatorcontrib>Mainar, Luis, MD</creatorcontrib><creatorcontrib>Pellicer, Mauricio, MD</creatorcontrib><creatorcontrib>Sanz, Roberto, PhD</creatorcontrib><creatorcontrib>Gomez, Cristina, PhD</creatorcontrib><creatorcontrib>Bosch, Maria J., MD</creatorcontrib><creatorcontrib>Husser, Oliver</creatorcontrib><creatorcontrib>Chorro, Francisco J., MD, FESC</creatorcontrib><creatorcontrib>Llacer, Angel, MD, FESC</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>The American heart journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bodí, Vicente, MD, FESC</au><au>Sanchis, Juan, MD, FESC</au><au>Lopez-Lereu, Maria P., MD</au><au>Nunez, Julio, MD</au><au>Mainar, Luis, MD</au><au>Pellicer, Mauricio, MD</au><au>Sanz, Roberto, PhD</au><au>Gomez, Cristina, PhD</au><au>Bosch, Maria J., MD</au><au>Husser, Oliver</au><au>Chorro, Francisco J., MD, FESC</au><au>Llacer, Angel, MD, FESC</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction</atitle><jtitle>The American heart journal</jtitle><addtitle>Am Heart J</addtitle><date>2007-04-01</date><risdate>2007</risdate><volume>153</volume><issue>4</issue><spage>649</spage><epage>655</epage><pages>649-655</pages><issn>0002-8703</issn><eissn>1097-6744</eissn><coden>AHJOA2</coden><abstract>Background The objective of this study was to evaluate the simultaneous evolution of 5 cardiovascular magnetic resonance–derived myocardial viability indexes. Methods We studied 72 patients with a first ST-elevation myocardial infarction and sustained TIMI 3 flow. In the first week and in the sixth month of the study, using cardiovascular magnetic resonance imaging, we determined wall thickening (WT) and the following viability indexes: wall thickness, WT with low-dose dobutamine, microvascular perfusion in first-pass imaging, microvascular obstruction in late-enhancement imaging, and transmural extent of necrosis. Results In 250 dysfunctional segments, the evolution outcomes for the viability indexes were as follows: (1) wall thickness thinned (8.6 ± 2.9 versus 7.7 ± 3 mm, P < .001), (2) WT with low-dose dobutamine improved (1.5 ± 1.9 versus 2.6 ± 3 mm, P < .001), (3) the number of segments showing abnormal microvascular perfusion in first-pass imaging decreased (22% versus 7%, P < .001), (4) the number of segments showing microvascular obstruction in late-enhancement imaging decreased (14% versus 2%, P < .001), and (5) the transmural extent of necrosis remained stable throughout follow-up (56% ± 40% versus 54% ± 39%, P = .3). Conclusions After reperfused myocardial infarction, dynamic changes in wall thickness, contractile reserve, microvascular perfusion, and microvascular obstruction take place. These changes may affect their accuracy as viability indexes early after myocardial infarction. The transmural extent of necrosis does not vary, however.</abstract><cop>New York, NY</cop><pub>Mosby, Inc</pub><pmid>17383307</pmid><doi>10.1016/j.ahj.2006.12.023</doi><tpages>7</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0002-8703 |
| ispartof | The American heart journal, 2007-04, Vol.153 (4), p.649-655 |
| issn | 0002-8703 1097-6744 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_70313584 |
| source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Angioplasty Biological and medical sciences Cardiology Cardiology. Vascular system Cardiovascular Confidence intervals Coronary heart disease Enzymes Female Heart Heart attacks Humans Intubation Magnetic Resonance Imaging Male Medical sciences Middle Aged Myocardial Infarction - diagnosis Myocardial Infarction - therapy Myocardial Reperfusion Studies Veins & arteries |
| title | Evolution of 5 cardiovascular magnetic resonance–derived viability indexes after reperfused myocardial infarction |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T15%3A57%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Evolution%20of%205%20cardiovascular%20magnetic%20resonance%E2%80%93derived%20viability%20indexes%20after%20reperfused%20myocardial%20infarction&rft.jtitle=The%20American%20heart%20journal&rft.au=Bod%C3%AD,%20Vicente,%20MD,%20FESC&rft.date=2007-04-01&rft.volume=153&rft.issue=4&rft.spage=649&rft.epage=655&rft.pages=649-655&rft.issn=0002-8703&rft.eissn=1097-6744&rft.coden=AHJOA2&rft_id=info:doi/10.1016/j.ahj.2006.12.023&rft_dat=%3Cproquest_cross%3E3238237781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1504609354&rft_id=info:pmid/17383307&rft_els_id=1_s2_0_S0002870307000580&rfr_iscdi=true |